Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Non-Current Deferred Tax Liability (2025 - 2026)

Updated

Northwest Biotherapeutics' Non-Current Deferred Tax Liability came in at $12.96 million for Q2 2026, up 0.2% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

At the end of FY2025, Northwest Biotherapeutics' Non-Current Deferred Tax Liability was $13.17 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.96 Mn
Mar 31, 2026 12.94 Mn
Dec 31, 2025 13.17 Mn
API Access

Northwest Biotherapeutics Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NWBO&period=max&api_key=YOUR_API_KEY